RBC begins coverage of Alphatec at outperform

RBC Capital Markets analyst David C. Clair initiated coverage of Alphatec Holdings, Inc. with an outperform rating, above average risk. Alphatec is a fast-growing company in the orthopedic sector, with a focus on the fusion market. The analyst is modeling 94.4% revenue growth to $82.3 million, with a 12-month price target of $13. Shares of the Carlsbad, Calif.-based medical device company were down 29 cents, or 4.65%, at $5.94 on volume of 76,861 shares versus the three-month running average of 77,154 shares. (Nasdaq: ATEC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.